This website uses cookies, pixels, and similar technologies (“cookies”), some of which are provided by third parties, to enable website features and functionality; measure, analyze, and improve site performance; enhance user experience; record user interactions; and support our advertising and marketing. We and our third-party vendors may monitor, record, and access information and data, including device data, IP address and online identifiers, referring URLs and other browsing information, for these and similar purposes. By clicking “Accept all cookies,” you agree to such purposes. If you continue to browse our site without clicking “Accept all cookies,” or if you click “Reject all cookies,” only cookies necessary to operate and enable default website features and functionalities will be deployed. If you are visiting our Site in the U.S., by using this site or clicking “Accept all cookies,” “Reject all cookies,” or “Preferences,” you acknowledge and agree to our Privacy Policy, Cookie Policy, and Terms of Use.

library

IQT News
/
No items found.

908 Devices and IQT Enter Strategic Partnership to Develop New Mass Spectrometry Analyzers

Read the Paper

April 9, 2013

908 Devices, an innovator in field-portable chemical analysis, today announced it has entered into a strategic partnership with In-Q-Tel (IQT), the independent strategic investment firm that identifies innovative technology solutions to support the missions of the U.S. Intelligence Community. The investment will contribute to 908 Devices' efforts to build rugged, handheld mass spectrometry tools that can perform hazardous chemical detection and analysis. The technology is being developed, in part, with funding from the Department of Homeland Security Science and Technology Directorate, an IQT customer agency.

"The team at 908 Devices is implementing Mass Spectrometry in a form factor that truly is handheld, and their capabilities are strongly aligned with needs we see in both government and commercial markets," said Simon Davidson, Partner on IQT's Investments team. "We believe this partnership will provide our government customers in the national security space with a unique opportunity to deploy and build upon unprecedented capabilities for chemical detection and analysis."

908 Devices makes simple and purpose-built, battery-powered tools that provide chemical detection and analysis at the point-of-need, untethered from permanent facilities or mobile laboratories. Truly handheld, and weighing only a few pounds, these analyzers are far beyond the unwieldy and complex ‚ 'luggable' systems available today. 908 Devices' proprietary High Pressure Mass Spectrometry (HP-MS‚Ñ¢) technology gives non-specialist field personnel analysis with extreme sensitivity — to the part-per-billion level or lower — while simultaneously distinguishing thousands of different chemicals.

"The need to detect and analyze a broad array of hazardous chemicals and weapons at trace amounts has never been greater," said Dr. Kevin J. Knopp, CEO and founder of 908 Devices. "We are pleased to be partnering with IQT, and believe this significant partnership validates our platform and approach."

About 908 Devices
908 Devices is bringing the powerful capabilities of Mass Spectrometry out of the confines of centralized laboratories. 908 Devices' products range from rugged, handheld chemical detection tools to compact, dedicated analyzers for researchers, serving a range of industries including safety and security, food science, biotechnology and clinical diagnostics. Founded in 2012 by a proven team of industry and technology veterans, 908 Devices is based in Boston's Innovation District.

No items found.